New anticancer treatment technology targets cancer cell lysosomes and overcomes drug resistance
A groundbreaking anticancer treatment technology that selectively targets cancer cell lysosomes and overcomes drug resistance has been developed by Professor Ja-Hyoung Ryu and his research team in the Department of Chemistry at UNIST. This pioneering research promises a new paradigm for chemical anticancer drugs in the future. Lysosomes are crucial organelles responsible for breaking down … Read more